AstraZeneca announces tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON & TITANIA phase III trials: Cam ...

With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a ...

AstraZeneca announced that full results from the positive Phase III OBERON and TITANIA trials showed that tozorakimab is the first biologic to demonstrate statistically significant and highly ...

The Biologics License Application for tozorakimab 300mg, administered once every four weeks, has been accepted for Priority Review by the US Food and Drug Administration as an add-on maintenance ...

The FDA has started a priority review of AstraZeneca's IL-33-targeting antibody tozorakimab for chronic obstructive pulmonary ...

An Evansville mother has filed a wrongful death lawsuit claiming that the Vanderburgh County Department of Child Services ...

In your 9th month and wondering when labor might start? 👀 Here are some common signs that your body may be getting ready, from period-like cramps and increased pelvic pressure to losing your mucus ...

A wrongful death lawsuit has been filed by an Evansville mother who lost her three-year-old son.

Going home with a new tracheostomy can feel intimidating, but following instructions from your care team and establishing a ...

At ERS 2026, AstraZeneca presented new Phase III data on the impact of tozorakimab versus placebo on mucus plugs in patients with COPD.

AstraZeneca said on 8 September 2026 that the US Food and Drug Administration has accepted for Priority Review its Biologics ...

A third of U.S. adults fail to get the recommended minimum of seven hours of daily sleep. As many as 70 million Americans ...